Biblioteca En este apartado se irán dando a conocer publicaciones científicas de interés en el campo de la Radiofarmacia Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses Ver Detalle First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma Ver Detalle 99mTc‑labeled FAPI compounds for cancer and infammation: from radiochemistry to the first clinical applications Ver Detalle Desarrollo y validación de un procedimiento alternativo para realizar los controles de pureza radioquímica de radiofármacos de 99mTc con un contador Geiger Müller Ver Detalle First-in-Human 212Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer Ver Detalle Risk Management in Good Manufacturing Practice (GMP) Radiopharmaceutical Preparations Ver Detalle Effectiveness and Safety of Retreatment with 177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States Ver Detalle Radionuclide Theranostics in Neuroendocrine Neoplasms: AnUpdate Ver Detalle Prostate Cancer Theranostics With 177Lu-PSMA Ver Detalle PET/TC con FAPI: procedimiento y revisión de la evidencia en oncología Ver Detalle End of content No more articles to load
Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses Ver Detalle
First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma Ver Detalle
99mTc‑labeled FAPI compounds for cancer and infammation: from radiochemistry to the first clinical applications Ver Detalle
Desarrollo y validación de un procedimiento alternativo para realizar los controles de pureza radioquímica de radiofármacos de 99mTc con un contador Geiger Müller Ver Detalle
First-in-Human 212Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer Ver Detalle
Effectiveness and Safety of Retreatment with 177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States Ver Detalle